4.8 (207) In stock
The Quebec-based pharmacy company had $47.8 million or 26 cents per share of net income in its fourth quarter, ended March 4 — down seven per cent from the comparable period last year.
Solved Sales and Collections Information: BBJ: Basic Blue
JOURNAL OF INTERNATIONAL BUSINESS & LAW - Hofstra Law
Disconnect between gold prices and gold stocks - Video - BNN
Beyond Meat tops quarterly revenue estimates, plans 'steep' cost cuts in 2024
Canadian Tire profit slips as inflation prompts 'mindful' consumers to cut spending - BNN Bloomberg
Mulling Over Margin, Part 1: Introduction and Historical Background - farmdoc daily
Shipping Shifts From Jackpot to Job Cuts After $364 Billion Boom - BNN Bloomberg
Obesity Drug WeGovy to Drive Up Profits at Novo Nordisk - Bloomberg
In Pictures: The Richest People In The World
In Pictures: The Richest People In The World
US Producer Prices Increased by More Than Forecast in January - BNN Bloomberg
Novo Nordisk Forecasts Record Profit Fueled by Obesity Drug - Bloomberg
Jean Coutu profits up despite generics
Jean Coutu profits up despite generics
